Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study-Reference-Cited by-同舟云学术

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study

Published:2016-03-02 Issue:9 Volume:65 Page:1439-1446
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Murakami Kazunari,Sakurai Yuuichi,Shiino Madoka,Funao Nobuo,Nishimura Akira,Asaka Masahiro

Funder

Takeda Pharmaceutical Company

Publisher

BMJ

Subject

Gastroenterology

Reference30 articles.

1. Helicobacter pylori infection;Suerbaum;N Engl J Med,2002

2. Clinical practice. Helicobacter pylori infection;McColl;N Engl J Med,2010

3. A new approach for elimination of gastric cancer deaths in Japan;Asaka;Int J Cancer,2013

4. The burden of selected digestive diseases in the United States;Sandler;Gastroenterology,2002

5. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough;Gisbert;Aliment Pharmacol Ther,2011

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis;BMC Infectious Diseases;2024-09-11

2. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection;American Journal of Gastroenterology;2024-09

3. Efficacy and safety of tegoprazan‐ and rabeprazole‐based concomitant therapies for Helicobacter pylori infection: Real‐world evidence;Journal of Gastroenterology and Hepatology;2024-08-26

4. Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of <i>Helicobacter pylori</i> in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials;Biological and Pharmaceutical Bulletin;2024-08-01

5. A Comprehensive Review on the Efficacy and Safety of Vonoprazan in the Management of Gastric Acid-Related Diseases;Cureus;2024-07-17